SEOUL: South Korea’s SK bioscience said on Monday it plans to expand vaccine production by investing about 150 billion won (US$132 million) by 2024 to add production capacity, as well as equipping its plant to make newer mRNA and viral vector vaccines. The vaccine maker said in a statement it …
